drugset / Trial / NCT01529242
Comparison of Desloratadine Associated With Prednisolone Oral Solution Versus Dexchlorpheniramine Associated With Betamethasone for Cutaneous Rash Treatment
RandomizedParallel-groupQuadruple-blindTreatment
Summary
The purpose of this study is to evaluate the non-inferiority clinical efficacy of two different drug associations in the treatment of acute cutaneous rash in children between 2 and 12 years old.
Timeline
- Start
- 2014-02
- Primary completion
- 2016-08
- Completion
- 2016-10-20
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Betamethasone | Other / unclassified | 0.125 mg | Oral |
| Comparator | Betamethasone | Other / unclassified | 0.25 mg | Oral |
| Subject | Desloratadine | Small molecule | 1.25 mg | Oral |
| Subject | Desloratadine | Small molecule | 2.5 mg | Oral |
| Comparator | Dexchlorpheniramine | Unknown | 1 mg | Oral |
| Comparator | Dexchlorpheniramine | Unknown | 2 mg | Oral |
| Subject | Prednisolone | Other / unclassified | 10 mg | Oral |
| Subject | Prednisolone | Other / unclassified | 20 mg | Oral |